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Renal calcium oxalate binding protein: Studies on its properties. To
understand the mechanism of calcium oxalate (CaOx) crystal retention
within the kidneys, calcium oxalate binding protein was isolated and
characterized. The specific activity of calcium oxalate binding protein in
the homogenate was 4.54 nmol/mg protein. The renal medulla showed
higher CaOx binding activity than that of papilla or cortex, and among the
cellular fractions the nucleus exhibited highest specific activity. Several
tissues showed CaOx binding activity suggesting its ubiquitous nature.
After being subjected to acetone precipitation, ethanol precipitation and
HPLC chromatography, the renal protein revealed a 57-fold purity with a
specific activity of 260 nmol/mg protein and a molecular weight of 45 kDa.
The CaOx binding protein had the kinetic properties of concentration and
time dependency, optimum temperature and substrate saturability. Scat-
chard plot analysis showed a single affinity site with a kDa of 41 nM and
Bmax of 6.7 nmol/mg protein. The binding activity was inhibited by the
anion transport inhibitor DIDS and substrate analogs like succinate and
oxamide, while EGTA or ruthenium red had no effect on binding,
suggesting that the protein binding was oxalate site specific. The molecular
weight of the CaOx binding protein of different tissues was similar to that
of renal cells. In conclusion, the presence of CaOx binding protein is
demonstrated in rat and human kidneys, as well as other rat tissues.
The interaction between renal epithelial cells and calcium
oxalate (CaOx) crystals/oxalate ions has been suggested to play a
critical role for the formation as well as retention of calcium
oxalate stone [1]. Several studies have shown that cellular mem-
branes [2], damaged proximal tubules and loop of Henle, and
injured urothelium after treatment with gentamycin [3] induce
nucleation of CaOx crystals at a lower supersaturation. Membrane
damage due to lipid peroxidation or depletion of cellular antioxi-
dants has been suggested as a predisposing factor for CaOx crystal
deposition [4, 5], and administration of vitamin E or methionine
prevents CaOx retention [6–8]. Oxalate binding proteins have
been identified and characterized in human and rat kidney
mitochondria [9] and nucleus [10], intestinal cytosol [11], vitamin
B6-deficient rat intestinal brush border membranes [12] and
bacterial system [13]. Several CaOx crystal associated proteins
have been isolated from matrix of stones [14] or urine crystals
[15]. All these proteins are found to be derived from different
tissues and the existence of any specific protein involved in stone
retention is not known. Some of the basement membrane com-
ponents have a high affinity for CaOx crystals and promote crystal
adhesion [16]. To understand the mechanism of CaOx retention
within the kidneys, it is necessary to identify the CaOx binding
factor. This communication presents the data for the presence of
a CaOx binding protein in renal cells as well as other tissues.
METHODS
Adult male albino rats of the Wistar strain weighing 180 to
200 g, obtained from Tamil Nadu Veterinary University, Chennai
were used for the study. The animals were fed with standard rat
pellet diet supplied by M/s. Hindustan Lever Ltd. (Bombay, India)
and water was provided ad libitum.
[14C]-oxalate was purchased from Babha Atomic Research
Centre (BARC; Bombay, India), which has a specific activity of
5.86 mCi/mmol/ml. 2-(N-morpholino) ethane sulphonic acid
(MES) and 3-(N-morpholino)-propanesulphonic acid (MOPS)
were obtained from Sigma Chemical Company (St. Louis, MO,
USA). Millipore membrane filters 0.45 mm were obtained from
Millipore India Ltd. (Bangalore, India). All other chemicals,
reagents and solvents used were of the analytical grade from
Glaxo Laboratories (BDH Chemicals, Bombay, India).
Subcellular fractionation
Rat tissues were excised from the animals following cervical
decapitation and quickly dropped into ice-cold saline. Twenty
percent rat tissue homogenate was made from 0.01 M TRIS-HCL
CONTAINING 0.25 M sucrose pH 7.4, and then the mixture was
subjected to differential centrifugation. Pellets obtained after
800 3 g for 15 minutes and 8000 3 g for 20 minutes were the
nuclear and mitochondrial fractions, respectively. The remaining
supernatant was for the post-mitochondrial fraction.
Preparation of calcium [14C]-oxalate monohydrate crystals
Calcium [14C]-oxalate monohydrate (CaOx*) crystals were syn-
thesized essentially as described by Meyer and Smith [17].
Assay of calcium oxalate binding protein
Calcium oxalate binding activity was estimated by the method
described by Laxmanan et al [18] for oxalate binding with a slight
modification.
A 20% homogenate was prepared in MES buffer (0.1 M, pH
5.5). An aliquot of the homogenate or the subcellular fractions
suspended in MES buffer (0.1 M pH 5.5) was incubated in 1 ml of
0.1 M MES buffer (pH 5.5) containing 60 nmol CaOx* (3120 cpm;
52 cpm/nmol) at room temperature for 45 minutes. The incuba-
tion mixture was filtered through a 0.45 mm Millipore membrane
filter with the aid of a constant vacuum. Nonspecific binding was
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determined as the radioactivity retained by the filter in the
presence of 13 mmol cold oxalate. The filters were dried and
placed in mini vials to which 4.0 ml scintillation fluid was added,
and the CaOx* was measured in a Betamatic IV liquid scintilla-
tion counter. Specific activity of oxalate binding was expressed as
nmol/mg protein.
Purification of calcium oxalate binding protein from human
kidney, rat kidney and other rat tissues
One milliliter of 20% tissue homogenate prepared in MES
buffer (0.1 M, pH 5.5), and CaOx* (50,000 cpm), HCl (0.05 N, 300
ml) and MOPS buffer (0.1 M, pH 7.4, 1.5 ml) were added. The
results were mixed well and incubated for one hour at room
temperature.
Step I: Delipidation by organic solvents
This step was based on the method of Findlay [19] with slight
modifications. (1.) To 1.75 ml of the above incubation mixture 7.5
ml of cold chloroform methanol (2:1 vol/vol) were added. (2.) This
was shaken vigorously and centrifuged at 3000 3 g for five
minutes. The clear upper part of the intermediate layer was
aspirated out and used for the acetone precipitation.
Step II: Acetone precipitation
The aspirated layer of step I was added to an equal amount of
ice cold acetone, stirred and left at 4°C for six hours. Then the
mixture was centrifuged at 10,000 3 g for 20 minutes.
Step III: Ethanol precipitation
Acetone precipitate obtained from 500 mg of rat kidney alone
was dissolved in 1 ml MES buffer (0.1 M, pH 5.5) and added to two
volumes of ice cold ethanol. The mixture was left at 4°C overnight
before centrifugation at 10,000 3 g for 15 minutes.
High pressure liquid chromatography
A modified method of Brewer and Sassenfeld [20] was used.
The protein precipitates of steps II and III were suspended in
suitable amount of MES buffer (0.1 M, pH 5.5) and 25 ml was
loaded onto a high pressure liquid chromatography (HPLC) TSK
3000 Supelco gel permeation column that was fitted to LC-8A
Schimadzu liquid chromatograph with a SPD 6A UV spectropho-
tometer detector. The CaOx* bound protein peak was monitored
at 204 nm and radioactivity was measured.
Marker proteins were also run under similar conditions to
determine the molecular weight of the desired protein.
RESULTS
Calcium oxalate binding was studied in different regions of rat
and human kidneys (Table 1). Maximal CaOx binding was ob-
served in the medullary region of both rat and human kidney,
followed by the papilla and cortex regions.
The ubiquitous nature of CaOx binding protein was found by its
binding with various subcellular fractions of different tissues
(Table 2). Kidney, liver, spleen and brain showed good binding
activity, while the lungs and intestine showed poor activity.
Among the different subcellular fractions in all of the tissues, the
nucleus showed the highest CaOx binding activity.
Kinetic studies on calcium oxalate binding protein
Calcium oxalate binding activity increased linearly up to a
protein concentration of 900 mg (specific activity 5 4.54 nmol),
and above that concentration there was no further increase in
binding for both rat and human kidney homogenates. Hence,
further studies were carried out at the protein concentration of
500 mg.
Calcium oxalate binding was linear up to 45 minutes, after
which there was no further increase in binding activity in both rat
and human kidney. Experiments were carried out with a 60-
minute incubation time.
Maximal CaOx binding was seen at pH 5.5 and further studies
were carried out at that pH. The optimum temperature for CaOx
binding was 30°C.
Calcium oxalate binding activities were studied with increasing
CaOx concentrations from 5 to 150 mM. The CaOx binding activity
was dependent on the concentration of calcium oxalate in the
medium. The saturation concentration of CaOx binding was
observed above 80 mM (Fig. 1). Scatchard plot analysis was carried
out by plotting bound CaOx/free CaOx ratio versus bound CaOx.
As shown in Figure 2, the dissociation constant (Kd) of rat and
human kidney CaOx binding proteins were computed to be 39.7
and 39.49 nM, and the maximum binding (Bmax) to be 6.5 nmol
and 6.2 nmol/mg protein, respectively.
To determine the specificity of CaOx binding of rat and human
kidney protein,studies were carried out in the presence of oxam-
ide, citrate, glycolate and glyoxylate (Table 3). Of all the analogs,
succinate showed the maximum inhibition and glyoxylate showed
the minimum inhibition for both rat and human kidney proteins.
Table 1. Calcium oxalate (CaOx) binding activity in cortex and medulla











Cortex 2.96 6 0.15 420 6 30 2.77 6 0.14 401 6 25
Medulla 6.30 6 0.45 794 6 49 5.92 6 0.44 753 6 5
Papilla 5.65 6 0.4 583 6 37
Homogenate of cortex, medulla or papilla (500 mg) was incubated with
CaOx, and the radioactivity retained with the membrane filter discs was
measured as described in the Methods section. Values are expressed as
mean 6 SD of six experiments.
Table 2. Calcium oxalate (CaOx) binding in subcellular fractions of
different tissues of rat and human kidney
Tissues




Brain 3.20 6 0.21 4.17 6 0.30 1.62 6 0.12 1.00 6 0.05
Lungs 1.36 6 0.07 2.52 6 0.17 1.10 6 0.07 0.78 6 0.03
Spleen 4.23 6 0.31 6.08 6 0.45 2.85 6 0.17 1.18 6 0.09
Heart 2.98 6 0.22 5.48 6 0.39 1.02 6 0.04 1.00 6 0.05
Small
intestine 0.98 6 0.06 0.82 6 0.05 0.91 6 0.06 0.61 6 0.04
Liver 3.81 6 0.27 5.60 6 0.42 2.15 6 0.19 0.97 6 0.07
Kidney
rat 4.54 6 0.25 6.54 6 0.5 2.74 6 0.21 1.01 6 0.06
Kidney
human 4.20 6 0.2 5.93 6 0.48 3.10 6 0.27 1.02 6 0.06
Values are expressed as mean 6 SD of six experiments.
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However, none were able to inhibit CaOx binding completely,
thus demonstrating high specificity of CaOx binding to rat and
human kidney proteins.
Thiol reagents were found to inhibit CaOx binding activity of
both rat and human kidney protein by 30% to 60%, but oxidized
glutathione had no effect. Sulphate and carbonates inhibited
CaOx binding very effectively whereas EGTA, ruthenium red and
MgCl2 did not affect CaOx binding.
Calcium oxalate binding was inhibited linearly with increasing
DIDS concentration up to 0.5 mM, above which there was no
further inhibition of binding (Fig. 3).
Purification of calcium oxalate binding protein
Calcium oxalate binding protein was purified from 4.25 ml of
20% rat kidney homogenate with a total protein concentration of
112.6 mg, and the total bound CaOx* was 511.32 nmol. The
specific activity of CaOx binding protein of rat kidney homogenate
was found to be 4.54 nmol CaOx/mg protein, and this was
increased to 25.2 nmol when the homogenate was extracted with
chloroform and methanol, as described in the Methods section,
with a yield of 50%. Acetone precipitate of this extract showed
29.7% yield and 22-fold purity. Further precipitate with ethanol
gave 10% yield with 45-fold purity, and the specific activity was
Fig. 1. Effect of substrate concentration on calcium oxalate (CaOx)
binding in rat (F) and human (1) kidney homogenates.
Fig. 2. Scatchard plot of calcium oxalate (CaOx) binding activity in
kidney homogenates of rat (E) and human (F).
Table 3. Effect of substrate analogs, thiol modifiers, Ca21 chelators
and interferers on (CaOx) binding in kidney homogenate
Additives
2 mM






None 4.54 6 0.25 100 4.20 6 0.24 100
Oxamide 1.31 6 0.06b 29 1.80 6 0.1b 43
Succinate 0.60 6 0.02b 13 1.91 6 0.12 46
Malate 1.98 6 0.12b 44 2.50 6 0.15b 60
Trisodium citrate 1.89 6 0.11b 42 2.10 6 0.14b 50
Glycolate 2.64 6 0.17b 58 2.70 6 0.19b 64
Glyoxylate 3.10 6 0.21b 68 3.20 6 0.25b 76
Phenyl succinate 1.40 6 0.1 31 1.62 6 0.11b 39
N-ethyl maleimide 2.66 6 0.19b 59 2.16 6 0.17b 51
p-chloromercury
benzoate
3.46 6 0.24b 76 2.5 6 0.19b 60
GSSG 4.37 6 0.35 96 4.1 6 0.31 98
GSH 1.62 6 0.11b 36 2.35 6 0.17b 56
b-mercaptoethanol 3.1 6 0.22b 68 3.2 6 0.2b 76
Dithiothrietol 1.65 6 0.13b 36 1.92 6 0.16b 46
EGTA 4.20 6 0.23 93 4.19 6 0.2 100
Ruthenium red 5.20 6 0.25a 115 4.30 6 0.23 102
CaCl2 z 2H2O 3.09 6 0.19
b 86 3.60 6 0.17b 86
MgCl2 z 6H2O 4.38 6 0.24 97 4.21 6 0.23 100
Na2SO4 1.05 6 0.1
b 23 0.90 6 0.03b 21
NaHCO3 2.19 6 0.17
b 48 2.10 6 0.15b 50
Values are expressed as mean 6 SD of six experiments. a P , 0.01; b P ,
0.001 vs. control.
Fig. 3. Effect of DIDS on calcium oxalate (CaOx) binding in rat (F) and
human (1) kidney homogenates.
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101 nmol/mg protein. The precipitate was loaded onto HPLC
column and the elution of CaOx binding protein was monitored by
measuring radioactivity of CaOx bound protein peak. The CaOx
binding protein had a specific activity of 260 nmol/mg protein and
showed 57-fold purity with a final yield of 6.2%.
Calf-thymus histone
To determine whether histone protein was responsible for
CaOx binding (Selvam and Prasannalakshmi [10], Selvam and
Kannabiran [21]), calf-thymus histone (H1) was incubated with
CaOx, and then extracted with chloroform-methanol followed by
precipitation with acetone, as described for the purification of
CaOx binding protein in the Methods section. There was little
CaOx binding activity in the acetone precipitate, suggesting that
proteins other than histones were responsible for the CaOx
binding.
Molecular weight of calcium oxalate binding protein
The acetone precipitate of different tissues of rat and human
kidney and the ethanol precipitate of rat kidney were loaded onto
a HPLC column. From the calibration curve of standard molec-
ular weight markers the molecular weight of CaOx binding
protein of these tissues was computed to be around 45 to 47 kDa.
The specific activity of CaOx binding protein in the acetone
precipitate of each tissue was between 190 and 207 nmol/mg
protein, whereas the specific activity in ethanol precipitate was
260 nmol of CaOx*/mg protein.
DISCUSSION
Calcium oxalate binding activity is enriched in the nuclear
fraction of renal cells of both human and rat tissue. The same is
true of the other tissues examined in this study. Liver and spleen
are the other tissues having good calcium oxalate binding activity.
The physiological significance of nuclear binding in renal cells as
well as other tissues is not well understood, however, there is
evidence showing that the binding may be physiologically impor-
tant for certain nuclear function. Lieske et al [22] demonstrated
that monkey kidney epithelial cells (BSC-1) in culture can also
internalize CaOx crystals and undergo proliferation in the pres-
ence of the crystals. Internalized crystals are found to be distrib-
uted to daughter cells during cell division. It has recently been
shown by Hammes et al [23] that CaOx crystals induce expression
of immediate early genes C-myc, C-jun, EGR-1 and NVR-77 and
genes encoding plasminogen activator inhibitor (PAI-1) and
platelet-derived growth factor (PDGF)-A in BAC-1 kidney epi-
thelial cells in primary cultures of rat proximal tubular epithelium
exposed to oxidative stress [24].
Calcium oxalate crystals have been observed in normal thyroid
tissue [25] and mammary gland [26]. The presence of these
crystals is attributed to the normal function of thyroid gland, since
these crystals are absent in abnormal function.
The calcium oxalate binding protein has the following charac-
teristic properties of saturation of binding: optimum pH at 5.5,
time and temperature dependency, substrate specificity, inhibition
by oxalate analogs but not by calcium chelators, and inhibition of
binding by thiol modifiers and the anion transport inhibitor,
DIDS.
Saturation studies reveal the maximal CaOx binding at about 5
nmol of CaOx/mg protein. This suggests that about 100 to 120 mg
CaOx can bind per gram of tissue. Binding is maximal at pH 5.5.
Laxmanan et al [18] have demonstrated maximal oxalate binding
in rat kidney mitochondria at pH 6.0. Oxalate binding histone
protein has exhibited maximal binding at pH 4.2 [10].
The CaOx binding data by Scatchard plot analysis reveals the
presence of a single type of binding site. This is similar to the
oxalate binding protein of rat and human mitochondria [9], which
exhibits a single affinity site. However, the presence of two types
of affinity sites, one with a high affinity and the other with a low
affinity for oxalate, has been reported for histone-oxalate binding
protein [10, 21] and for intestinal brush border membrane vesicle
(BBMV) oxalate binding protein of vitamin B6-deficient rats [27].
Effect of substrate analogs
Calcium oxalate binding proteins of rat and human kidney
homogenate seem to be highly specific for oxalate and are only
partially inhibited by substrate analogs. The structurally related
compounds to oxalate are better inhibitors than dicarboxylates or
tricarboxylates, showing high specificity of oxalate binding. Similar
findings have been reported by Laxmanan et al [18]. Further
inhibition of CaOx binding by bicarbonate and sulphate suggests
that these anions are much more effective inhibitors than sub-
strate analogs. Similar observations have been reported in cell
culture studies [28].
The Ca21 chelators and interferers such as EGTA, ruthenium
red, CaCl2 and MgCl2, do not affect CaOx binding activity. This
proves that it is only the oxalate moiety that is responsible for
specific binding of CaOx and not calcium. Our observations are in
contrast to the cytosolic oxalate binding protein of human intes-
tine [11], which is Ca21 dependent.
Characterization of calcium oxalate binding protein
The purified calcium oxalate binding protein shows a specific
activity of 260 nmol/mg protein. Rat protein has a molecular
weight of 45 kDa as determined by HPLC. Various oxalate
transport/binding proteins with different molecular weights from
different sources have been isolated, purified and characterized
[10–12, 29, 30].
The presence of CaOx binding protein in different tissues
suggests its ubiquitous nature. Further CaOx binding is not
confined to one particular subcellular fraction. It is present in the
nucleus, mitochondria and microsomal fractions of all the tissues
tested. The nuclear CaOx binding is not due to histone-oxalate
binding protein, since histone H1 does not show CaOx binding
activity when subjected to a similar treatment of protein extrac-
tion as that of CaOx binding protein. The approximate molecular
weight of the CaOx binding protein of different tissues deter-
mined by HPLC is found in the range of 45 to 47 kDa.
The tissues, kidney and liver that are handling oxalate show a
higher CaOx binding activity than most other tissues except
spleen. Though CaOx binding protein is present in a number of
tissues studied, only kidney is known to form calcium oxalate
stones; other tissues do not form stones. In pathological condi-
tions such as systematic oxalosis, many tissues including dermis
[31], testis [32] and joint fluid [33] are deposited with CaOx. This
implies that sufficient saturation may not exist in other tissues for
the initiation of nucleation even in the presence of CaOx binding
protein, whereas a saturation of CaOx is possible in the kidney
that results in hyperoxaluria, and initiation of nucleation can be
aided by CaOx binding proteins.
Sloughed cellular membranes are shown to induce nucleation
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of CaOx crystals at a lower supersaturation. and can also be
involved in crystal aggregation and retention. Further, it is shown
that some of the basement membrane components having a high
affinity for CaOx may help to promote crystal adhesion [34]. The
significance of the occurrence of CaOx binding protein in the
subcellular fractions is not well understood. However, studies by
Khan [35] suggest that crystal retention occurs by adherence to
other cells, and they move from lumen to cellular and then to the
interstitium. Tubular epithelial cells endocytose the crystals on the
luminal side and exocytose them on the basolateral side. Conse-
quently, crystals move from the lumen to the interstitial location
in the kidney. In the process, crystals come into contact with the
basement membrane, to which they bind and are thus anchored in
the kidneys. These observations suggest that CaOx crystals move
from one side of the cell to other side for permanent attachment.
This process may be facilitated by the presence of CaOx binding
protein in different subcellular fractions.
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